{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:58:52Z","timestamp":1791291532430,"version":"4.3.0"},"reference-count":33,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1554,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arthritis & Rheumatism"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1002\/art.30318","type":"journal-article","created":{"date-parts":[[2011,3,18]],"date-time":"2011-03-18T18:51:46Z","timestamp":1300474306000},"page":"1718-1728","source":"Crossref","is-referenced-by-count":130,"title":["Interferon and alternative activation of monocyte\/macrophages in systemic sclerosis-associated pulmonary arterial hypertension"],"prefix":"10.1002","volume":"63","author":[{"given":"Romy B.","family":"Christmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Everett","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Pendergrass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Padilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"Farina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alsya J.","family":"Affandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael L.","family":"Whitfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harrison W.","family":"Farber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Lafyatis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,5,31]]},"reference":[{"key":"10.1002\/art.30318-BIB1|cit1","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/art.10775","article-title":"Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement","volume":"48","author":"Steen","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"Suppl 3","key":"10.1002\/art.30318-BIB2|cit2","doi-asserted-by":"crossref","first-page":"iii40","DOI":"10.1093\/rheumatology\/kep109","article-title":"Pulmonary complications: one of the most challenging complications of systemic sclerosis","volume":"48","author":"Wells","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1002\/art.30318-BIB3|cit3","doi-asserted-by":"crossref","first-page":"e12106","DOI":"10.1371\/journal.pone.0012106","article-title":"Limited systemic sclerosis patients with pulmonary arterial hypertension show biomarkers of inflammation and vascular injury","volume":"5","author":"Pendergrass","year":"2010","journal-title":"PLoS One"},{"key":"10.1002\/art.30318-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/art.22382","article-title":"A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and Toll-like receptor agonists","volume":"56","author":"York","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1002\/art.30318-BIB5|cit5","first-page":"1281","article-title":"Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis","volume":"22","author":"Clements","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1002\/art.30318-BIB6|cit6","doi-asserted-by":"crossref","first-page":"7303","DOI":"10.4049\/jimmunol.177.10.7303","article-title":"Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression","volume":"177","author":"Martinez","year":"2006","journal-title":"J Immunol"},{"key":"10.1002\/art.30318-BIB7|cit7","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/nri2448","article-title":"Exploring the full spectrum of macrophage activation","volume":"8","author":"Mosser","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1002\/art.30318-BIB8|cit8","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1146\/annurev.immunol.021908.132532","article-title":"Alternative activation of macrophages: an immunologic functional perspective","volume":"27","author":"Martinez","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"10.1002\/art.30318-BIB9|cit9","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","article-title":"Preliminary criteria for the classification of systemic sclerosis (scleroderma)","volume":"23","author":"Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee","year":"1980","journal-title":"Arthritis Rheum"},{"key":"10.1002\/art.30318-BIB10|cit10","first-page":"84","article-title":"The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis","volume":"25","author":"Furst","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1002\/art.30318-BIB11|cit11","first-page":"1005","article-title":"Prevalence and characteristics of moderate to severe pulmonary hypertension in systemic sclerosis with and without interstitial lung disease","volume":"34","author":"Launay","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1002\/art.30318-BIB12|cit12","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1136\/ard.2007.086850","article-title":"Cartilage oligomeric matrix protein expression in systemic sclerosis reveals heterogeneity of dermal fibroblast responses to transforming growth factor \u03b2","volume":"68","author":"Farina","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1002\/art.30318-BIB13|cit13","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/art.27220","article-title":"A four-gene biomarker predicts skin disease in patients with diffuse cutaneous systemic sclerosis","volume":"62","author":"Farina","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1002\/art.30318-BIB14|cit14","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1086\/314859","article-title":"In vivo and in vitro induction of MxA protein in peripheral blood mononuclear cells from patients chronically infected with hepatitis C virus","volume":"180","author":"Fernandez","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1002\/art.30318-BIB15|cit15","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1067\/mai.2003.1333","article-title":"IL-13 receptors and signaling pathways: an evolving web","volume":"111","author":"Hershey","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1002\/art.30318-BIB16|cit16","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1159\/000087185","article-title":"Chemokine receptor CCR1: a new target for progressive kidney disease","volume":"25","author":"Ninichuk","year":"2005","journal-title":"Am J Nephrol"},{"key":"10.1002\/art.30318-BIB17|cit17","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1253\/circj.72.469","article-title":"IL-13 attenuates vascular tube formation via JAK2-STAT6 pathway","volume":"72","author":"Nishimura","year":"2008","journal-title":"Circ J"},{"key":"10.1002\/art.30318-BIB18|cit18","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1084\/jem.176.1.287","article-title":"Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation","volume":"176","author":"Stein","year":"1992","journal-title":"J Exp Med"},{"key":"10.1002\/art.30318-BIB19|cit19","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1146\/annurev.immunol.23.021704.115816","article-title":"Macrophage receptors and immune recognition","volume":"23","author":"Taylor","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"10.1002\/art.30318-BIB20|cit20","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1189\/jlb.72.3.580","article-title":"IL-13 signal transduction in human monocytes: phosphorylation of receptor components, association with Jaks, and phosphorylation\/activation of Stats","volume":"72","author":"Roy","year":"2002","journal-title":"J Leukoc Biol"},{"key":"10.1002\/art.30318-BIB21|cit21","doi-asserted-by":"crossref","first-page":"R147","DOI":"10.1186\/ar2821","article-title":"Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations","volume":"11","author":"Gourh","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1002\/art.30318-BIB22|cit22","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1164\/rccm.200909-1367OC","article-title":"Dysregulation of the IL-13 receptor system: a novel pathomechanism in pulmonary arterial hypertension","volume":"182","author":"Hecker","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1002\/art.30318-BIB23|cit23","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1084\/jem.20071008","article-title":"Pulmonary arterial remodeling induced by a Th2 immune response","volume":"205","author":"Daley","year":"2008","journal-title":"J Exp Med"},{"key":"10.1002\/art.30318-BIB24|cit24","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1165\/rcmb.2002-0032OC","article-title":"Leukotrienes mediate murine bronchopulmonary hyperreactivity, inflammation, and part of mucosal metaplasia and tissue injury induced by recombinant murine interleukin-13","volume":"28","author":"Vargaftig","year":"2003","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1002\/art.30318-BIB25|cit25","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1007\/s10620-010-1220-7","article-title":"Irreversible pulmonary hypertension associated with the use of interferon \u03b1 for chronic hepatitis C","volume":"55","author":"Dhillon","year":"2010","journal-title":"Dig Dis Sci"},{"key":"10.1002\/art.30318-BIB26|cit26","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s002770100298","article-title":"Pulmonary artery hypertension during interferon-\u03b1 therapy for chronic myelogenous leukemia","volume":"80","author":"Fruehauf","year":"2001","journal-title":"Ann Hematol"},{"key":"10.1002\/art.30318-BIB27|cit27","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1476-7120-3-26","article-title":"Long-term therapy of interferon-\u03b1 induced pulmonary arterial hypertension with different PDE-5 inhibitors: a case report","volume":"3","author":"Jochmann","year":"2005","journal-title":"Cardiovasc Ultrasound"},{"key":"10.1002\/art.30318-BIB28|cit28","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1177\/1352458509104593","article-title":"Pulmonary arterial hypertension associated with interferon \u03b2 treatment for multiple sclerosis: a case report","volume":"15","author":"Ledinek","year":"2009","journal-title":"Mult Scler"},{"key":"10.1002\/art.30318-BIB29|cit29","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1136\/ard.2009.121400","article-title":"Type I interferon system activation and association with disease manifestations in systemic sclerosis","volume":"69","author":"Eloranta","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1002\/art.30318-BIB30|cit30","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1164\/rccm.200312-1686OC","article-title":"Gene microarray analysis of peripheral blood cells in pulmonary arterial hypertension","volume":"170","author":"Bull","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1002\/art.30318-BIB31|cit31","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.trsl.2007.12.010","article-title":"Identification of candidate genes in scleroderma-related pulmonary arterial hypertension","volume":"151","author":"Grigoryev","year":"2008","journal-title":"Transl Res"},{"key":"10.1002\/art.30318-BIB32|cit32","doi-asserted-by":"crossref","first-page":"H2021","DOI":"10.1152\/ajpheart.00919.2001","article-title":"Anti-monocyte chemoattractant protein-1 gene therapy attenuates pulmonary hypertension in rats","volume":"283","author":"Ikeda","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1002\/art.30318-BIB33|cit33","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nri2314","article-title":"Interferon-inducible antiviral effectors","volume":"8","author":"Sadler","year":"2008","journal-title":"Nat Rev Immunol"}],"container-title":["Arthritis & Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fart.30318","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/art.30318","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T20:45:23Z","timestamp":1685997923000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/art.30318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,31]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"URL":"https:\/\/doi.org\/10.1002\/art.30318","relation":{},"ISSN":["0004-3591"],"issn-type":[{"value":"0004-3591","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5,31]]}}}